Support for enhancing study drug adherence in HIV prevention trials
Ended Awarded Last action
- Contract number
- HHSN27200009
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $844,713
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2015029 Solicitation number
- Comprehensive Resources for HIV Microbicides and Biomedical Prevention Award Notice · Posted Jun 24, 2015
- Contract value 100% obligated
- $844,713.24 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$877 | |
| Funding Only Action | $940 | |
| Funding Only Action | $10,620 | |
| Exercise an Option | $147,133 | |
| Exercise an Option | $143,776 | |
| Exercise an Option | $140,498 | |
| Exercise an Option | $137,302 | |
| Exercise an Option | $134,183 | |
| Original award | $131,138 |
About this award
This federal contract award, valued at $844,713.24, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL). The contract is for support in enhancing study drug adherence in HIV prevention trials, falling under NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention program. The contract is a cost-plus-fixed-fee delivery order under the larger HIV Microbicides and Biomedical Prevention 2016-2021 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. ABL is a leading contract research and manufacturing organization that specializes in developing biologics, including vaccines and immunotherapies, for infectious disease research and product development initiatives. There is no set-aside designation for this award.
Quick answers
Who was awarded contract HHSN27200009?
HHSN27200009 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 27, 2017.
How much is contract HHSN27200009 worth?
The government has obligated $844,713 on HHSN27200009.
Is contract HHSN27200009 an order under another contract?
Yes. HHSN27200009 is a delivery order under HHSN272201600008I, an indefinite delivery contract, on HIV Microbicides and Biomedical Prevention 2016-2021.
Was contract HHSN27200009 competed?
The extent of competition for HHSN27200009 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award